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Abstract
Background: The hypothalamic-pituitary-adrenal (HPA) axis, and in particular cortisol, has been reported to be
involved in obesity-associated metabolic disturbances in adults and in selected populations of adolescents. The aim
of this study was to investigate the association between morning adrenocorticotropic hormone (ACTH) and cortisol
levels and cardiovascular risk factors in overweight or obese Caucasian children and adolescents.
Methods: This cross-sectional study of 450 obese children and adolescents (aged 4 to 18 years) was performed in
a tertiary referral center. ACTH, cortisol, cardiovascular risk factors (fasting and post-challenge glucose, high-density
lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglycerides, and hypertension) and insulin
resistance were evaluated. All analyses were corrected for confounding factors (sex, age, puberty, body mass index),
and odds ratios were determined.
Results: ACTH and cortisol levels were positively associated with systolic and diastolic blood pressure, triglycerides,
fasting glucose and insulin resistance. Cortisol, but not ACTH, was also positively associated with LDL-cholesterol.
When adjusted for confounding factors, an association between ACTH and 2 h post-oral glucose tolerance test
glucose was revealed. After stratification according to cardiovascular risk factors and adjustment for possible
confounding factors, ACTH levels were significantly higher in subjects with triglycerides ≥90th percentile (P <0.02)
and impaired fasting glucose or glucose tolerance (P <0.001). Higher cortisol levels were found in subjects with
blood pressure ≥95th percentile and LDL-cholesterol ≥90th percentile. Overall, the highest tertiles of ACTH (>5.92
pmol/l) and cortisol (>383.5 nmol/l) although within the normal range were associated with increases in
cardiovascular risk factors in this population.
Conclusions: In obese children and adolescents, high morning ACTH and cortisol levels are associated with
cardiovascular risk factors. High ACTH levels are associated with high triglyceride levels and hyperglycemia, while
high cortisol is associated with hypertension and high LDL-cholesterol. These specific relationships suggest
complex mechanisms through which the HPA axis may contribute to metabolic impairments in obesity, and merit
further investigations.
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Background
The prevalence of obesity in children and adolescents has
increased over several decades in many countries [1,2].
This phenomenon has been accompanied by an increased
incidence of type 2 diabetes and metabolic syndrome
(MetS), which includes dyslipidemia and hypertension [3].
Cortisol has been reported to have a role in obesity,
hypertension, and the altered glucose and lipid profile in
Cushing’s syndrome, and some studies have suggested
that moderately increased morning fasting cortisol may be
associated with the presence of cardiovascular risk factors
in adults [4-6]. Abnormalities in the central regulation of
the hypothalamic-pituitary-adrenal (HPA) axis due to
stress may lead to a mild hypercortisolism in adults with
obesity and MetS [7,8]. Reinher and Andler found signifi-
cant associations between the degree of cortisolemia and
fasting insulin levels in obese children, and levels of both
hormones decreased following weight loss. These findings
suggested that, in children, there are similar mechanisms
to those reported in adults, and that higher cortisol levels
are first a consequence rather than a cause of comorbid-
ities in obesity [9]. A study in adolescents found racial/eth-
nic differences in daily cortisol secretion [10], but any
studies in children have been limited to select or small
populations. Two recent studies in overweight Latino
youths with a family history of type 2 diabetes, confirmed
higher fasting cortisol levels in those with lower insulin
sensitivity [11] or MetS, and an association with hyperten-
sion and high glucose levels [12]. However, a study in a
small group of prepubertal children showed higher morn-
ing plasma cortisol levels in those with higher total choles-
terol and triglycerides [13]. Although cortisol is associated
with metabolic alterations, it appears that adrenocortico-
tropic hormone (ACTH) may directly contribute to
comorbidities in obesity. It has been shown in vitro that
ACTH interacts with adipocytes, promotes insulin resis-
tance and is proinflammatory [14]. To date, however, the
role of ACTH has not been determined in obese children.
This study recruited a large cohort of overweight and
obese pediatric subjects to determine the following: (1) to
establish whether an association between cardiovascular
risk factors and morning cortisol levels is present in
obese Caucasian children and adolescents; (2) to evaluate
whether ACTH is associated with cardiovascular risk fac-
tors in this population; and (3) to establish whether
ACTH and cortisol levels are higher in those with speci-
fic cardiovascular risk factors.
Methods
Study design and population
This was a cross-sectional study. Study quality was assessed
using the checklist of STROBE (for ‘STrengthening the
Reporting of OBservational studies in Epidemiology’; Addi-
tional file 1). We consecutively recruited 450 children and
adolescents, aged 4 to 18 years, referred to the Pediatric
Endocrine Service of our Hospital from January 2008 to
October 2011 for obesity. The Hospital covers an area of
North-East Piedmont with a population of approximately
500,000. The sampling rate was based on the age structure
of the community and of the general pediatric population
referred to the Service. Subjects were eligible if they were
generally healthy, overweight or obese and not on a
weight-loss diet (no engagement in any program to lose
weight before the enrollment). Exclusion criteria were the
known presence of diabetes or high blood pressure (BP),
the use of drugs which influence glucose or lipid metabo-
lism, specific causes of endocrine or genetic obesity, low
birth weight, distress during blood sampling or a difficult
phlebotomy (more than 5 minutes).
The protocol was conducted in accordance with the
declaration of Helsinki and was approved by the Local
Inter-Hospital Ethic Committee (Maggiore Hospital Ethi-
cal Committee). Informed consent was obtained from all
parents prior to the evaluations after careful explanations
were given to each patient.
Anthropometric and biochemical measurements
All subjects underwent a clinical evaluation by a trained
research team. Pubertal stages were determined by physi-
cal examination, using the criteria of Marshall and Tan-
ner. Height was measured to the nearest 0.1 cm using a
Harpenden stadiometer, and body weight with light
clothing to the nearest 0.1 kg using a manual weighing
scale. Body mass index (BMI) was calculated as body
weight divided by squared height (kg/m2). The BMI stan-
dard deviation score (BMISDS) was calculated by the
least median squares method [15]. Waist circumference
was measured at the high point of the iliac crest around
the abdomen and was recorded to the nearest 0.1 cm.
Systolic BP (SBP) and diastolic BP (DBP) were measured
three times at 2-minute intervals using a mercury sphyg-
momanometer with an appropriate cuff size after partici-
pants were seated quietly for at least 15 minutes, with
their right arm supported at the level of the heart and
feet flat on the floor, prior to other physical evaluations,
and at least 30 minutes after blood sampling, using a
standard mercury sphygmomanometer. Mean values
were used for the analyses. Hypertension was determined
if BP values recorded on enrollment day and on blood
samples day are always elevated.
After a 12-hour overnight fast, children arrived at the
clinical center at 7.30 AM and rested comfortably for half
an hour prior to blood testing. At 8.00 AM, blood samples
were taken for measurement of ACTH, cortisol, glucose,
insulin, high-density lipoprotein (HDL)-cholesterol and
triglycerides. ACTH and cortisol samples were drawn first.
Subjects also underwent an oral glucose tolerance test
(OGTT; 1.75 g of glucose solution per kg, maximum
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75 g). Plasma samples were immediately separated and
stored at-80°C. Children were screened for symptoms sug-
gestive of Cushing’s syndrome, and a 1 mg overnight dexa-
methasone suppression test and urinary free cortisol
measurement were performed in case of suspicion. Signs
of Cushing’s syndrome were a low height percentile and
high weight percentile as suggested by the guidelines of
the Endocrine Society [16]. We also screened children for
a height below that expected from parental height or a
previous episode of severe hypertension. Children with
positive screenings were excluded.
Insulin resistance was calculated using the homoeostasis
model assessment of insulin resistance (HOMA-IR).
Low-density lipoprotein (LDL)-cholesterol was calculated
by the Friedwald formula. ACTH and cortisol levels were
measured by an Immulite 2000 Medical System (Medical
Systems S.p.A., Via Rio Torbido 40, Genova, Italy) (sensi-
tivity: <12.0 pmol/l and <27.59 nmol/l, respectively). Other
assays and formulas are as previously described [17].
Definitions
Subjects were classified as overweight (BMI: 75th to 94th
percentile) or obese (BMI: ≥95th percentile) according to
Italian growth charts [15]. Children and adolescents
underwent an evaluation for cardiovascular risk factors
identified in the classification of MetS and by using cut-
off values of the modified National Cholesterol Education
Program-Adult Treatment Panel (NCEP-ATP) III criteria
[18] as follows: (1) triglycerides ≥90th percentile for age
and sex; (2) HDL-cholesterol ≤10th percentile for age
and sex; and (3) impaired fasting glucose or glucose tol-
erance. High LDL-cholesterol was defined as ≥90th per-
centile for age and sex. Because of differences in the
literature, hypertension was defined according to two
specific cut-offs: (1) >95th percentile as suggested by the
National High Blood Pressure Education Program
(NHBPEP) Working Group of American Academy of
Pediatrics (AAP) [19]; and (2) >90th percentile as sug-
gested by definitions of pediatric MetS [18,20,21].
Triglyceride, LDL-cholesterol and HDL-cholesterol
cut-off levels for age and sex were those used in the Lipid
Research Clinic Pediatric Prevalence Study [22]. Impaired
fasting glucose and impaired glucose tolerance were
defined according to MetS and American Diabetes
Association classifications as fasting plasma glucose of
≥5.6 to 6.9 nmol/l, and as 2-h post-OGTT glucose of
≥7.8 to 11.0 nmol/l, respectively [18]. Both SBP and DBP
values were stratified according to percentiles of the
NHBPEP Working Group [19].
Statistical analysis
All data are expressed as mean ± standard deviation (SD),
absolute values or percentages. A sample of 84 indivi-
duals has been estimated to be sufficient to demonstrate
a difference of 27.59 µg/dl in cortisol with a SD of 2 with
90% power and a significance level of 95% using the
Student’s t test. Distributions of continuous variables
were examined for skewness and were logarithmically
transformed as appropriate. Correlation of ACTH and
cortisol with continuous values of SBP, DBP, triglycer-
ides, HDL-cholesterol and LDL-cholesterol, glucose,
insulin, and HOMA-IR were examined using Pearson
correlation coefficients. Partial correlation was used to
correct for covariates. Analysis of covariance was used to
determine differences in subjects with and without cardi-
ovascular risk factors. Covariates were sex, age, pubertal
stage, and BMI; BMISDS was used when the analysis was
not contemporarily corrected for age. Analysis of covar-
iance was also used to determine ACTH and cortisol dif-
ferences among age and pubertal subgroups, with
BMISDS (or BMI), HOMA-IR and sex as covariates.
ACTH and cortisol were also categorized into tertiles.
Multiple logistic regression was used to determine the
association of tertiles of ACTH and cortisol with the
odds ratio (OR, 95% CI) of each cardiovascular risk fac-
tor. Tertiles of ACTH and cortisol were included as inde-
pendent variables, with the first tertile as the reference
group. Statistical significance was assumed at P <0.05.
The statistical analysis was performed with SPSS for
Windows V.17.0 (SPSS Inc., Chicago, IL, USA).
Results
Anthropometric and metabolic phenotypes of all groups
The final dataset included 406 participants, aged 4 to 18
years (198 male, 208 female). A total of 29 subjects were
excluded because they did not satisfy inclusion criteria
(15 with difficult blood sampling, 5 with a low birth
weight, 4 with hypothyroidism in thyroiditis, and 5 treated
with glucocorticoids in the last 6 months). Other exclu-
sions were two subjects diagnosed with late-onset congeni-
tal adrenal hyperplasia, eight with distress during BP
monitoring, and five who refused the dexamethasone test.
A total of 31 out of 406 subjects had the dexamethasone
test and showed correct inhibition of cortisol levels (all
<27.59 µg/dl), so Cushing’s syndrome was excluded. We
performed 24-h urine sampling for free cortisol measure-
ment, but this was incomplete in 20 out of 31 patients.
ACTH levels were higher in Tanner 4 to 5 stage parti-
cipants (P <0.001) and in 14.0 to 15.9-year-olds (P <0.01)
in males than in females, and this was also the case in the
analysis corrected for BMISDS (or BMI) and HOMA-IR.
Cortisol levels were higher in Tanner 4 to 5 stage partici-
pants than in Tanner 1 stage participants for the whole
group (P <0.02), and in females (P <0.02); this was also
the case in the corrected analysis for BMISDS and
HOMA-IR (Figure 1).
A total of 97 (24.0%) subjects were overweight and 309
(76.0%) were obese. Of the 406 subjects included, 23 (5.7%)
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Figure 1 Tanner-dependent (A) and age-dependent (B) adrenocorticotropic hormone (ACTH) (pmol/l) and cortisol (nmol/l) levels in
406 overweight and obese children and adolescents (filled circles, males, left panel; open circles, females, right panel). Cortisol levels
were higher in the Tanner 4 to 5 stages than the Tanner 1 stage in the whole group (P <0.02*) and in females (P <0.02*). ACTH levels were
higher in Tanner 4 to 5 stages (P <0.001*) and in 14.0 to 15.9 years (P <0.01*) in males than in females. Significance was maintained when the
model included body mass index (BMI) (or BMI standard deviation score (BMISDS)) and homoeostasis model assessment of insulin resistance
(HOMA-IR) as covariates. *Indicates significance of analysis of covariance (ANCOVA) analysis.
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had impaired fasting glucose, 10 (2.5%) had impaired
glucose tolerance and 5 (1.2%) had both. None were dia-
betic. A total of 91 (22.4%) subjects had triglycerides ≥90th
percentile, 216 (53.2%) had HDL-cholesterol ≤10th percen-
tile and 25 (6.2%) had LDL-cholesterol ≥90th percentile for
age and sex. Hypertension according to NCEP-ATP criteria
was diagnosed in 339 (83.4%) subjects and in 274 (67.4%),
according to AAP criteria. Only 1 subject presented with all
cardiovascular risk factors, while 63 (15.5%) had none.
All clinical and biochemical characteristics are shown in
Tables 1 and 2.
Associations between ACTH, cortisol and metabolic
parameters
In the unadjusted analyses, ACTH and cortisol levels
were positively associated with SBP, DBP, triglycerides,
fasting glucose and HOMA-IR. ACTH, but not cortisol,
was positively associated with a higher BMI and insulin
levels. Cortisol, but not ACTH, was positively associated
with LDL-cholesterol levels (Table 3 and Additional file
2). Adjustment for confounding factors did not change
any association for ACTH and revealed a further associa-
tion with 2-h post-OGTT glucose. However, the associa-
tion between cortisol and HOMA-IR was lost after
adjustment (Table 3).
ACTH and cortisol levels and cardiovascular risk factors
In the unadjusted analyses, ACTH levels were higher in
those with triglycerides ≥90th percentile (P <0.003) and
LDL-cholesterol ≥90th percentile (P <0.04). Higher ACTH
levels were also observed in those with impaired fasting
glucose or glucose tolerance (P <0.001) and BP ≥95th per-
centile (P <0.009), but not in those with HDL-cholesterol
≤10th percentile and BP ≥90th percentile. Cortisol levels
were higher in individuals with LDL-cholesterol ≥90th
percentile (P <0.006) and BP ≥95th percentile (P <0.02).
In adjusted models, ACTH levels remained higher in
those with triglycerides ≥90th percentile (P <0.02) and
impaired fasting glucose or glucose tolerance (P <0.001).
Cortisol levels remained high in those with BP ≥95th
percentile and LDL-cholesterol ≥90th percentile.
Higher ACTH levels (third tertile >5.92 pmol/l), although
within the normal range, increased the odds of hyperten-
sion (>95th percentile), higher triglycerides, impaired fast-
ing or post-OGTT glucose tolerance in the univariate
analysis. After adjusting for confounding factors, only the
odds of higher triglycerides (OR 2.118, 95% CI 1.139 to
3.939), impaired fasting or post-OGTT glucose (OR 2.548,
95% CI 1.003 to 6.475) remained significant. Higher corti-
sol levels (third tertile, >383.5 nmol/l), although within the
normal range, increased the odds of hypertension (>95th
percentile; OR 1.593, 95% CI 1.002 to 3.133) and higher
LDL-cholesterol (OR 3.546, 95% CI 1.095 to 11.490) in
both univariate and multivariate analyses (Table 4).
Discussion
A series of studies in adults and a few studies in selected
groups of adolescents, have shown alterations in cortisol
in individuals with cardiovascular risk factors (for review
see [8,9,13]). In adults, abdominal obesity, high triglycer-
ide and low HDL-cholesterol levels, hypertension, hyper-
glycemia, MetS and chronic stress have all been
characterized by hyperactivity of the HPA axis leading
to a functional hypercortisolism. It has also been sug-
gested that inhibiting cortisol action could provide a
novel approach for these conditions [8].
In the present study, although ACTH and cortisol levels
were within the normal ranges, we observed higher ACTH
and cortisol levels in obese children and adolescents with
specific cardiovascular risk factors. In particular, ACTH
levels were higher in those with higher glucose and trigly-
ceride levels, while cortisol levels were higher in those
with hypertension and higher LDL-cholesterol, thereby
increasing the risk for these metabolic disturbances.
The first aim of our study was to determine whether
cortisol and ACTH were associated with cardiovascular
risk factors in obese Caucasian children and adolescents.
We showed that ACTH and cortisol were directly asso-
ciated with glucose, triglycerides, and BP independently of
sex, age, puberty, BMI and insulin resistance. Moreover,
cortisol was also associated with LDL-cholesterol. These
data suggest that the link between HPA and comorbidities
in obesity is present in very young children and that
elevated ACTH and cortisol levels, although within
normal ranges, are already associated with cardiovascular
risk factors. The data regarding cortisol are in agreement
with the study of Weigensberg and coworkers who
demonstrated that cortisol is higher in obese Latino youths
with MetS, independent of the degree of obesity and insu-
lin sensitivity [12]. Many studies evaluating cortisol in
pediatric obesity have demonstrated an association
between cortisol and insulin resistance, leading to hypoth-
esis that a relationship between cortisol and metabolic dis-
turbances would be mediated by insulin sensitivity
[9,11,13]. However, both our data and those from Latino
youths suggest that the relationship is complex and not
only due to insulin resistance. It is well known that Hispa-
nic people have a higher prevalence of type 2 diabetes and
cardiovascular diseases [20,23-25], thus such a selected
sample of subjects could have quite a different phenotype
linked to their genetic susceptibility. Despite this, however,
our data and that of others have shown that the associa-
tion with cardiovascular risk factors remains positive in
non-specific populations of obese children and adolescents
[9,13].
The lack of association between BMI and cortisol was
unexpected, particularly because an association was pre-
sent for ACTH. However, a number of studies have failed
to show an association [12,26-28]. Similar to the lack of
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Table 1 Biochemical and clinical characteristics of subjects
All Tanner 1 to 2 Tanner 2 to 3 Tanner 4 to 5
Subjects 406 154 140 112
M 198 93 75 30
F 208 61 65 82
Age, years 10.7 ± 3.1 8.4 ± 2.3 10.4 ± 2.0 14.2 ± 2.0
M 10.6 ± 2.8 9.0 ± 2.2 11.1 ± 2.1 14.6 ± 1.7
F 10.8 ± 3.4 7.6 ± 2.3 9.6 ± 1.5 14.0 ± 2.1
BMI, kg/m2 27.2 ± 4.8 25.2 ± 3.6 26.3 ± 4.0 31.1 ± 4.8
M 27.5 ± 4.8 26.1 ± 3.9 27.1 ± 4.1 32.7 ± 5.9
F 27.0 ± 4.8 23.9 ± 2.7 25.4 ± 3.8 30.6 ± 4.3
BMISDS 1.99 ± 0.59 1.95 ± 0.51 1.81 ± 0.53 2.26 ± 0.65
M 1.99 ± 0.57 1.98 ± 0.44 1.82 ± 0.55 2.40 ± 0.78
F 1.99 ± 0.60 1.90 ± 0.61 1.78 ± 0.50 2.21 ± 0.60
WC, cm 89.1 ± 13.2 82.5 ± 11.5 88.5 ± 11.1 100.1 ± 11.7
M 89.9 ± 13.2 84.8 ± 11.8 91.4 ± 11.2 104.4 ± 11.6
F 88.4 ± 13.3 79.0 ± 9.1 85.2 ± 10.2 98.7 ± 11.5
SBP, mmHg 127.1 ± 17.1 121.1 ± 12.6 125.6 ± 14.2 137.3 ± 21.1
M 128.7 ± 16.8 122.0 ± 13.1 129.2 ± 13.9 148.4 ± 19.0
F 125.6 ± 17.3 119.7 ± 11.8 121.4 ± 13.5 133.3 ± 20.4
DBP, mmHg 82.3 ± 10.9 78.7 ± 9.6 81.6 ± 10.6 88.0 ± 10.6
M 83.6 ± 10.8 80.1 ± 9.7 84.1 ± 10.3 93.4 ± 9.4
F 81.0 ± 10.8 76.4 ± 9.1 78.8 ± 10.3 86.0 ± 10.4
SBP percentile 90.4 ± 12.5 89.3 ± 12.2 89.7 ± 14.3 93.0 ± 10.1
M 91.0 ± 12.2 88.9 ± 12.5 91.6 ± 12.9 96.0 ± 6.2
F 89.9 ± 12.8 89.9 ± 10.7 87.4 ± 15.5 91.9 ± 11.0
DBP percentile 91.2 ± 11.5 90.5 ± 11.0 90.0 ± 12.9 93.7 ± 9.8
M 91.8 ± 11.4 91.0 ± 11.2 90.9 ± 12.8 96.8 ± 5.0
F 90.6 ± 11.6 89.9 ± 10.7 88.9 ± 13.0 92.6 ± 10.9
HDL, mmol/l 1.08 ± 0.24 1.15 ± 0.25 1.06 ± 0.23 1.00 ± 0.22
M 1.06 ± 0.23 1.13 ± 0.23 1.05 ± 0.22 0.91 ± 0.20
F 1.09 ± 0.25 1.18 ± 0.27 1.08 ± 0.25 1.04 ± 0.22
LDL, mmol/l 2.23 ± 0.59 2.36 ± 0.63 2.14 ± 0.54 2.18 ± 0.56
M 2.23 ± 0.63 2.37 ± 0.68 2.10 ± 0.53 2.16 ± 0.66
F 2.23 ± 0.54 2.35 ± 0.54 2.18 ± 0.55 2.19 ± 0.52
TG, mmol/l 0.87 ± 0.47 0.84 ± 0.46 0.84 ± 0.42 0.96 ± 0.54
M 0.88 ± 0.52 0.86 ± 0.47 0.83 ± 0.34 1.10 ± 0.89
F 0.86 ± 0.42 0.81 ± 0.44 0.85 ± 0.49 0.91 ± 0.32
Glc0’, mmol/l 4.80 ± 0.47 4.73 ± 0.51 4.79 ± 0.45 4.91 ± 0.39
M 4.89 ± 0.44 4.86 ± 0.46 4.85 ± 0.41 5.06 ± 0.39
F 4.72 ± 0.48 4.55 ± 0.54 4.72 ± 0.49 4.86 ± 0.38
Glc120’, mmol/l 6.05 ± 1.01 5.99 ± 0.90 6.11 ± 0.99 6.04 ± 1.13
M 6.09 ± 0.94 6.02 ± 0.91 6.02 ± 0.98 6.38 ± 0.91
F 6.00 ± 1.08 5.93 ± 0.89 6.25 ± 1.01 5.90 ± 1.18
Ins0’, pmol/l 97.3 ± 62.8 80.3 ± 50.3 101.1 ± 61.0 115.7 ± 73.9
M 92.6 ± 50.7 79.0 ± 44.6 100.2 ± 46.4 114.0 ± 66.3
F 101.8 ± 72.4 82.3 ± 58.0 102.2 ± 75.6 116.4 ± 77.0
HOMA-IR 2.9 ± 2.0 2.4 ± 1.6 3.0 ± 2.0 3.5 ± 2.4
M 2.8 ± 1.6 2.4 ± 1.4 3.0 ± 1.5 3.6 ± 2.2
F 3.0 ± 2.3 2.4 ± 1.8 3.0 ± 2.4 3.5 ± 2.4
ACTH, pmol/l 5.90 ± 4.70 5.37 ± 3.99 6.26 ± 5.88 6.17 ± 3.86
M 6.53 ± 5.49 5.79 ± 4.39 6.74 ± 5.99 8.20 ± 4.10
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an association between BMI and plasma cortisol in the
obese population, a lack of association between BMI or
body fat levels and urinary free cortisol and free cortisone
(in 24-h urine) has also been demonstrated in non-obese
children [29]. One explanation could be the homogenous
population in terms of weight in our and other studies.
However, it could be that ACTH is a better biomarker in
childhood in relation to obesity and associated cardiovas-
cular risk factors. Accordingly, major glucocorticoid meta-
bolites in 24-h urine samples (reflecting ACTH-driven
adrenocortical activity or cortisol secretion) were signifi-
cantly associated with body fat in non-obese children [29].
The latter findings, together with our cross-sectional
study, suggest that adrenocortical activity (driven by
ACTH) is related to body composition during growth
whether children are lean/normal weight [29] or obese.
However, in this context it is important that higher body
fat levels do not always imply higher total blood cortisol
although ACTH is increased. ACTH can be increased and
total circulating cortisol concomitantly reduced [30].
However, also in children reduced cortisol blood levels are
not uncommon in case of elevated body fat levels [31,32].
Moreover, our paper and that of Reinehr and Andler [9]
indicate that children’s total cortisol plasma levels are not
necessarily reduced if body fat is higher. However, really
elevated cortisol concentrations in obese children appear
to emerge only if a marked insulin resistance is also present
[9]. Interestingly, we also observed changes in ACTH and
cortisol levels at the last years and at the end of puberty.
Healthy adults have higher blood cortisol levels than chil-
dren. Adults also have clearly higher 24-h excretion rates
of free cortisol and free cortisone after correction for body
Table 3 Partial correlation for adrenocorticotropic
hormone (ACTH) (pmol/l) and cortisol (nmol/l) with
cardiovascular risk factors.
Model and factor ACTH Cortisol
r P value r P value
Model 1
SBP, mmHg 0.098 0.052 0.121 <0.01
DBP, mmHg 0.105 <0.03 0.119 <0.01
HDL, mmol/l -0.016 0.753 0.040 0.432
TG, mmol/l 0.144 <0.004 0.107 <0.03
LDL, mmol/l -0.002 0.961 0.123 <0.01
Glc0’, mmol/l 0.248 <0.0001 0.110 <0.02
Glc120’, mmol/l 0.144 <0.02 -0.020 0.712
Ins0’, pmol/l 0.122 <0.01 0.050 0.327
HOMA-IR 0.152 <0.003 0.065 0.200
Model 2
SBP, mmHg 0.100 <0.05 0.112 <0.03
DBP, mmHg 0.106 <0.04 0.124 <0.01
HDL, mmol/l -0.013 0.796 0.048 0.353
TG, mmol/l 0.128 <0.01 0.102 <0.04
LDL, mmol/l -0.019 0.712 0.116 <0.02
Glc0’, mmol/l 0.218 <0.0001 0.117 <0.02
Glc120’, mmol/l 0.128 <0.04 -0.030 0.638
Values in bold represent significant results. Partial correlation was adjusted for
gender, age, Tanner stage, and BMI in model 1 and for gender, age, Tanner
stage, BMI, and insulin resistance in model 2. Log transformation was used for
skewed variables. DBP = diastolic blood pressure; Glc0’ = fasting glucose;
Glc120’ = post-challenge glucose; HDL = high-density lipoprotein; HOMA-IR =
homeostatic model assessment insulin resistance; Ins0’ = fasting insulin; LDL =
low-density lipoprotein; SDB = systolic blood pressure; TG = triglycerides.
Table 2 Distribution of cardiovascular risk stratified for
weight and sex.
All OW OB
Subjects 406 97 (24.0%) 309 (76.0%)
M 198 47 151
F 208 50 158
Hypertension (>90° percentile) 339 (83.4%) 71 (17.4%) 268 (66.0%)
M 173 36 137
F 166 35 131
Hypertension (>95° percentile) 274 (67.4%) 49 (12.0%) 225 (55.4%)
M 141 25 116
F 133 24 109
HDL <10° percentile 216 (53.2%) 39 (9.6%) 177 (43.6%)
M 123 23 100
F 93 16 77
TG >90° percentile 91 (22.4%) 15 (3.6%) 76 (18.8%)
M 61 11 50
F 30 4 26
LDL >90° percentile 25 (6.2%) 8 (1.9%) 17 (4.3%)
M 17 5 12
F 8 3 5
Dysglycemia 38 (9.3%) 7 (1.7%) 31 (5.4%)
M 21 4 17
F 17 3 14
Data are expressed as absolute values or percentages. HDL = high-density
lipoprotein; LDL = low-density lipoprotein; OB = obese subjects; OW =
overweight subjects; TG = triglycerides.
Table 1 Biochemical and clinical characteristics of subjects (Continued)
F 5.30 ± 3.72 4.73 ± 3.21 5.70 ± 4.40 5.40 ± 3.40
Cortisol, nmol/l 327.9 ± 148.9 311.9 ± 138.2 320.3 ± 161.2 359.4 ± 140.8
M 324.8 ± 146.7 308.1 ± 135.6 327.8 ± 161.0 369.2 ± 137.2
F 330.8 ± 151.3 317.8 ± 143.0 313.6 ± 163.4 355.8 ± 142.8
Data are expressed as mean ± SD. BMI = body mass index; DBP = diastolic blood pressure; F = female; Glc0’ = fasting glucose; Glc120’ = post-challenge glucose;
HDL = high-density lipoprotein; HOMA-IR = homeostatic model assessment insulin resistance; Ins0’ = fasting insulin; LDL = low-density lipoprotein; M = male; SBP
= systolic blood pressure; TG = triglycerides; WC = waist circumference.
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surface area than children. However 24-h excretion of free
cortisol and free cortisone in healthy children up to an age
of about 14 years is constant after body surface area correc-
tion [29,33]. We showed in our obese cohort that cortisol
rose in Tanner 4 to 5 stage participants, particularly in
females. Conversely, ACTH was higher in males with
respect to females in the same pubertal stage and at the
age of 14.0 to 15.9 years in presence of still unmodified
cortisol levels. These data, with respect to what age ACTH
and cortisol start to increase, have to be considered in
future works on cortisol in obese adolescents.
We also demonstrated that ACTH levels were associated
with metabolic alterations in pediatric obesity, and that
some associations were stronger with respect to those of
cortisol, in particular insulin resistance. The characteristics
of this association suggest that higher ACTH levels could
better reflect the interplay between obesity and the HPA
axis, and that cortisol-binding globulin (CBG) may be
important. Higher CBG levels reduce the rate of cortisol
clearance, and thus reflect cortisol levels in plasma [34]. In
a large population study, CBG levels were negatively corre-
lated with BMI, BP and insulin resistance, perhaps indi-
cating suppression of CBG synthesis, or a CBG gene
polymorphism in obesity [35]. Since stress-induced corti-
sol pulses are elevated in obesity, lower CBG levels may
enhance the glucocorticoid action on tissues and also
increase the cortisol clearance. Because CBG is costained
with ACTH in corticotrophs and is colocalized with vaso-
pressin in the hypothalamus [34], lower CBG levels may
result in higher ACTH levels in obesity by regulating the
Table 4 Plasma adrenocorticotropic hormone (ACTH) (pmol/l) and cortisol (nmol/l) tertiles and obesity comorbidities
in logistic regression.
Factor Tertile ACTH Cortisol
OR 95% CI P value OR 95% CI P value
Hypertension I 1.000 1.000
II 1.088 0.661 to 1.821 0.719 1.071 0.646 to 1.778 0.789
III 1.907 1.107 to 3.286 <0.02 1.721 1.008 to 2.913 <0.04
HDL <10° percentile I 1.000 1.000
II 1.433 0.884 to 2.323 0.145 0.866 0.549 to 1.429 0.619
III 1.439 0.886 to 2.338 0.141 1.993 0.610 to 1.614 0.976
TG >90° percentile I 1.000 1.000
II 1.182 0.631 to 2.212 0.601 0.981 0.545 to 1.768 0.950
III 2.367 1.319 to 4.248 <0.004 1.410 0.798 to 1.491 0.237
LDL >90° percentile I 1.000 1.000
II 2.181 0.655 to 7.263 0.204 2.520 0.676 to 7.490 0.186
III 3.098 0.973 to 9.866 0.056 3.223 1.012 to 10.265 <0.04
Dysglycemia I 1.000 1.000
II 1.659 0.632 to 4.356 0.304 1.161 0.484 to 2.788 0.738
III 2.959 1.198 to 7.307 <0.01 1.699 0.740 to 3.900 0.211
Hypertensiona I 1.000 1.000
II 1.033 0.603 to 1.769 0.906 1.042 0.607 to 1.790 0.882
III 1.668 0.978 to 2.966 0.072 1.593 1.002 to 3.133 <0.04
HDL <10° percentilea I 1.000 1.000
II 1.287 0.771 to 2.148 0.335 0.817 0.489 to 1.365 0.440
III 1.090 0.649 to 1.832 0.745 0.868 0.514 to 1.467 0.598
TG >90° percentilea I 1.000 1.000
III 1.050 0.546 to 2.019 0.884 1.075 0.578 to 2.000 0.819
III 2.118 1.139 to 3.939 <0.01 1.559 0.851 to 2.856 0.150
LDL >90° percentilea I 1.000 1.000
II 2.279 0.678 to 7.665 0.183 2.286 0.678 to 7.725 0.183
III 3.179 0.975 to10.365 0.055 3.546 1.095 to 11.490 <0.03
Dysglycemiaa I 1.000 1.000
II 1.582 0.593 to 4.217 0.359 1.040 0.421 to 2.570 0.932
III 2.548 1.003 to 6.475 <0.04 1.516 0.641 to 3.585 0.344
Values in bold represent significant results. Hypertension was considered as >95° percentile. aAdjusted for gender, age, Tanner stage, and BMI. ACTH tertiles were
subdivided as: I = <3.54 pmol/l; II = 3.54 to 5.92 pmol/l; III = >5.92 pmol/l. Cortisol tertiles were subdivided as: I = <240.0 nmol/l; II = 240.0 to 383.5 nmol/l;
III = >383.5nmol/l. BMI = body mass index; CI = confidence interval; HDL = high-density lipoprotein; LDL = low-density lipoprotein; OR = odds ratio; TG = triglycerides.
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HPA stress response. However, ACTH levels also repre-
sent expression of the negative feedback loop formed by
corticotropin-releasing hormone and cortisol, which is
influenced by genetic differences in the glucocorticoid
receptor [36].
The highest tertiles of the normal ranges of ACTH and
cortisol levels in this study were associated with an
increased risk of higher triglyceride and LDL-cholesterol
levels, respectively. The specific associations for ACTH
and cortisol were of interest. The association between
cortisol and LDL-cholesterol could be a consequence of
multifactorial mechanisms, including direct and indirect
effects on lipolysis, free fatty acid production and turn-
over, and very-low-density lipoprotein synthesis and fatty
acid accumulation in the liver (for review see [8,37]). The
association between ACTH and triglycerides may be sec-
ondary to the strong association between ACTH and
insulin resistance in our study. Moreover, ACTH has
been shown to increase apolipoprotein E levels in
humans, a key protein in determining triglyceride meta-
bolism [38]. However, a higher ACTH-driven adrenocor-
tical activity could have consequences for the hepatic fat
and triglyceride metabolism likely through a higher hepa-
tic glucocorticoid metabolism [8,37].
Higher ACTH levels, although within the normal
range, were also associated with fasting and post-chal-
lenge glucose, and ACTH levels were strong predictors
of hyperglycemia. These data are in line with findings in
obese Latino youths [11,12], suggesting that changes in
the HPA in altered glucose conditions are present also in
a broader population. The relationship between glucose
and cortisol is in line with glucocorticoid effects on hepa-
tic gluconeogenesis, insulin secretion and resistance
[8,39]. However, only ACTH increased the risk of high
glucose levels. These findings are concordant with the
evidence that lower daily cortisol levels and normal CBG
concentrations have been shown in childhood obesity as
an age-dependent mechanism to prevent type 2 diabetes
[32]. Because ACTH-driven adrenocortical activity or
cortisol secretion has been shown associated with body
fat in childhood, as previously discussed [29], ACTH
might also associate with higher glucose levels before
overt disease. In agreement with this hypothesis is that
none of the subjects in the present study had overt type
2 diabetes, but they had impaired fasting glucose or glu-
cose tolerance. We also found higher cortisol levels,
although within the normal range, in subjects with
higher BP, reflecting the data in Latino youths [12]. It is
interesting to note that when a cut-off was imposed, cor-
tisol levels were significantly higher only with respect to
the 95th percentile of BP, whereas there was no signifi-
cant association with the 90th percentile, which is sug-
gested as pathological in the MetS definition [18], and is
prehypertensive according to the NHBPEP Working
Group definition [19]. The lack of an association
between cortisol and hypertension using the lower BP
cut-off suggests that cortisol levels may be increased
only in overt disease. HPA alterations are thus likely to
be a consequence of obesity comorbidities, as is also sug-
gested by normalization of cortisol levels after weight
reduction [9].
There are limitations in the present study. First is the
cross-sectional design, in which we could not determine
whether slightly higher ACTH and cortisol levels were a
consequence rather than a cause of cardiovascular risk fac-
tors in pediatric obesity. Longitudinal studies might clarify
this aspect. The second limitation was the inability to
define the length of exposure to HPA alterations. The third
limitation was evaluation of the HPA without the evalua-
tion of urinary free cortisol. It is difficult to collect daily
urine samples properly in pediatric cases, in particular in
younger children. In fact, urinary samples were incomplete
in most of the children who also took the dexamethasone
test for exclusion of Cushing syndrome. However, a single
morning fasting cortisol measurement has been shown to
be associated with chronic stress and metabolic distur-
bances [40]. The fourth limitation was the lack of precise
data on socioeconomic status due to the refusal of many
parents. Socioeconomic status has been found to affect
chronic stress and cortisol levels and its role needs to be
explored further. The fifth limitation was the absence of
true body fat measurements through radiological techni-
ques. However, BMI is a good surrogate for body fat in
obesity in large epidemiological sample sizes [41]. The final
limitation was the lack of a control group. It would, how-
ever, be difficult to choose a good control group for our
purpose. Our population was followed in a tertiary care
center, and a healthy population of schoolchildren would
not be completely comparable in terms of chronic stress.
Conversely, the strength of the study was the large sample
size, the measurement of post-challenge glucose levels, and
the evaluation of many confounding factors.
Conclusions
In summary, we have shown that obese children and ado-
lescents with cardiovascular risk factors have higher
ACTH and cortisol levels, although still within the normal
range. These findings have led to the hypothesis that the
HPA is involved in obesity comorbidities early in life and
in a broad population. Higher ACTH levels are specifically
associated with higher triglyceride levels and hyperglyce-
mia, whereas higher cortisol levels are specifically asso-
ciated with hypertension and high LDL-cholesterol levels.
These specific associations suggest complex mechanisms
between the HPA axis and metabolic impairments in
obesity.
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